These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29849118)

  • 1. Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.
    Chow M; Gao L; MacManiman JD; Bicocca VT; Chang BH; Alumkal JJ; Tyner JW
    Oncogene; 2018 Sep; 37(38):5221-5232. PubMed ID: 29849118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
    Liu Z; Liu J; Zhang T; Shi M; Chen X; Chen Y; Yu J
    Pharmacol Res; 2020 Jan; 151():104512. PubMed ID: 31726100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.
    Widhopf GF; Cui B; Ghia EM; Chen L; Messer K; Shen Z; Briggs SP; Croce CM; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Jan; 111(2):793-8. PubMed ID: 24379361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ROR1 identifies new treatment strategies in hematological cancers.
    Karvonen H; Niininen W; Murumägi A; Ungureanu D
    Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
    Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
    Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
    Yao J; Luo Y; Zeng C; He H; Zhang X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia.
    Mouawad N; Ruggeri E; Capasso G; Martinello L; Visentin A; Frezzato F; Trentin L
    Hematol Oncol; 2024 Mar; 42(2):e3250. PubMed ID: 38949887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
    Hudecek M; Schmitt TM; Baskar S; Lupo-Stanghellini MT; Nishida T; Yamamoto TN; Bleakley M; Turtle CJ; Chang WC; Greisman HA; Wood B; Maloney DG; Jensen MC; Rader C; Riddell SR
    Blood; 2010 Nov; 116(22):4532-41. PubMed ID: 20702778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.
    Hasan MK; Rassenti L; Widhopf GF; Yu J; Kipps TJ
    Leukemia; 2019 Mar; 33(3):653-661. PubMed ID: 30568170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia.
    Sanchez-Lopez E; Ghia EM; Antonucci L; Sharma N; Rassenti LZ; Xu J; Sun B; Kipps TJ; Karin M
    Cell Death Differ; 2020 Jul; 27(7):2206-2216. PubMed ID: 31992855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
    Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J
    PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.
    Deniger DC; Yu J; Huls MH; Figliola MJ; Mi T; Maiti SN; Widhopf GF; Hurton LV; Thokala R; Singh H; Olivares S; Champlin RE; Wierda WG; Kipps TJ; Cooper LJ
    PLoS One; 2015; 10(6):e0128151. PubMed ID: 26030772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.
    Li P; Harris D; Liu Z; Liu J; Keating M; Estrov Z
    PLoS One; 2010 Jul; 5(7):e11859. PubMed ID: 20686606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.
    Hasan MK; Yu J; Widhopf GF; Rassenti LZ; Chen L; Shen Z; Briggs SP; Neuberg DS; Kipps TJ
    Blood; 2018 Jul; 132(2):170-178. PubMed ID: 29678828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.
    Choi MY; Widhopf GF; Ghia EM; Kidwell RL; Hasan MK; Yu J; Rassenti LZ; Chen L; Chen Y; Pittman E; Pu M; Messer K; Prussak CE; Castro JE; Jamieson C; Kipps TJ
    Cell Stem Cell; 2018 Jun; 22(6):951-959.e3. PubMed ID: 29859176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.
    Boukhari A; Alhosin M; Bronner C; Sagini K; Truchot C; Sick E; Schini-Kerth VB; André P; Mély Y; Mousli M; Gies JP
    Anticancer Res; 2015 Jan; 35(1):149-57. PubMed ID: 25550546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.
    Wang Q; Lu B; Zhang Y; Yu J; Guo J; Zhou Q; Lv H; Sun Y
    Hum Cell; 2021 Nov; 34(6):1855-1865. PubMed ID: 34370268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
    Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
    Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia.
    Broome HE; Rassenti LZ; Wang HY; Meyer LM; Kipps TJ
    Leuk Res; 2011 Oct; 35(10):1390-4. PubMed ID: 21813176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing UHRF1 enhances cell autophagy to prevent articular chondrocytes from apoptosis in osteoarthritis through PI3K/AKT/mTOR signaling pathway.
    Shi X; Han L; Sun T; Zhang F; Ji S; Zhang M; Wang X; Yang W
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1018-1024. PubMed ID: 32819559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.